BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1089792)

  • 21. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin and other surface antigens of cells of the immune system.
    Takahashi T; Old LJ; McIntire KR; Boyse EA
    J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte markers in non-Hodgkin's lymphomas.
    Payne SV; Smith JL; Jones DB; Wright DH
    Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T or B cell origin of some non-Hodgkin's lymphomas.
    Peter CR; MacKenzie MR; Glassy FJ
    Lancet; 1974 Sep; 2(7882):686-9. PubMed ID: 4142961
    [No Abstract]   [Full Text] [Related]  

  • 25. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between Ig-synthesis patterns and lymphoma classification.
    Hannam-Harris AC; Gordon J; Wright DH; Smith JL
    Br J Cancer; 1982 Aug; 46(2):167-72. PubMed ID: 6817774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of cells binding erythrocyte-antibody (EA) complexes in human lymphoid populations.
    Samarut C; Brochier J; Revillard JP
    Scand J Immunol; 1976; 5(3):221-31. PubMed ID: 1084016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathology of follicular lymphomas. A model of B-lymphocyte homing.
    Warnke R; Levy R
    N Engl J Med; 1978 Mar; 298(9):481-6. PubMed ID: 414136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin D-bearing lymphocytes in primary immunodeficiencies.
    Preud'Homme JL; Clauvel JP; Seligmann M
    J Immunol; 1975 Jan; 114(1 Pt 2):481-5. PubMed ID: 1090663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of immunoglobulin-containing cells in bone marrow and lymphoid tissues in patients with monoclonal gammapathy.
    Turesson I
    Acta Med Scand; 1978; 203(4):247-55. PubMed ID: 347889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface marker studies in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
    Leong AS; Forbes IJ; Cowled PA; Sage RE; Black RB; Dale B; Zalewski PD
    Pathology; 1979 Jul; 11(3):461-71. PubMed ID: 392424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.